GGrantIndex
Sort

11,323 grants matching glioblastoma

Mechanisms Regulating Chronic Immune Activation in the CNS

$1,551,284
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Increasing the therapeutic index of brain tumor treatment through innovative FLASH radiotherapy

$1,538,120
Charles Limoli · University Of California-Irvine · P01 · FY2023 · CA

Characterizing germline and somatic alterations by glioma subtypes and clinical outcome

$1,529,801
Melissa L Bondy · Stanford University · R01 · FY2021 · CA

MSKCC Center for Molecular Imaging in Cancer

$1,524,418
Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2013 · CA

Molecular Pathogenesis

$1,511,881
Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Neuro-oncology

$1,511,881
Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Regulation of ADP-ribosylation factor

$1,506,574
Paul A Randazzo · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Molecular Pathogenesis of Neoplasia

$1,501,258
Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

Molecular Pathogenesis of Pediatric High Grade Glioma

$1,499,530
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2018 · CA

Characterizing germline and somatic alterations by glioma subtypes and clinical outcome

$1,498,836
Melissa L Bondy · Stanford University · R01 · FY2022 · CA

TAS::75 0849::TAS SBIR TOPIC 255 PHASE II DEVELOPMENT OF ANTICANCER AGENTS

$1,496,764
Catherine Burkhart · Buffalo Biolabs, Llc · N44 · FY2011 · CA

DCTD Screening Technologies

$1,490,565
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

Progress Report for Neurotherapeutics Unit

$1,481,330
Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS

CLINICAL DEVELOPMENT OF CAR T CELL THERAPY TARGETING CD70 IN PRIMARY GLIOBLASTOMA

$1,473,470
University Of Florida · · FY2020 · Defense Health Agency

Molecular Determinants of Cancer Therapeutic Response

$1,471,838
Raymond J Monnat · University Of Washington · P01 · FY2015 · CA

MSKCC Center for Molecular Imaging in Cancer

$1,471,710
Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2015 · CA

Genetic and molecular epidemiology of adult glioma

$1,461,568
Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2011 · CA

Mechanisms Underlying Clearance of Persistent Infections and Tumors

$1,461,102
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

Molecular Determinants of Cancer Therapeutic Response

$1,458,213
Raymond J Monnat · University Of Washington · P01 · FY2016 · CA

Molecular Determinants of Cancer Therapeutic Response

$1,458,213
Raymond J Monnat · University Of Washington · P01 · FY2018 · CA

Molecular Determinants of Cancer Therapeutic Response

$1,458,213
Raymond J Monnat · University Of Washington · P01 · FY2017 · CA

MSKCC Center for Molecular Imaging in Cancer

$1,455,670
Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2014 · CA

Genetic and molecular epidemiology of adult glioma

$1,451,972
Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2012 · CA

p53, Aging, and Cancer

$1,444,352
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Gene Therapy for Brain Tumors

$1,440,815
Fred H Hochberg · Massachusetts General Hospital · P01 · FY2010 · CA